Texas 2017 - 85th Regular

Texas Senate Bill SB2030

Caption

Relating to the performance and appeal of utilization review by and under the direction of physicians.

Impact

By implementing these changes, SB2030 could significantly alter the landscape of utilization review processes within Texas' healthcare system. It mandates that appeals of adverse determinations regarding medical care must be decided by a physician licensed within Texas. Furthermore, if a healthcare provider requests a specialty review, the individual reviewing the case must also be licensed and in the same or a related specialty, all of which emphasizes in-state expertise in critical healthcare decisions.

Summary

Senate Bill 2030 aims to amend the Insurance Code by enhancing the framework for utilization reviews conducted by physicians. The bill stipulates that only physicians licensed to practice in the state can oversee and perform these reviews, thereby ensuring that medical decisions are made by qualified professionals familiar with state-specific regulations. This change is particularly significant as it seeks to address concerns about the quality and appropriateness of healthcare determinations made by unlicensed or out-of-state practitioners.

Contention

There may be potential points of contention surrounding the enforcement of these changes. Opponents might argue that such restrictions could limit the pool of available reviewers, possibly leading to delays in the appeals process. Additionally, the requirement for state licensure could be seen as a barrier to entry for out-of-state medical professionals who could provide valuable services in Texas. Balancing the need for local oversight with the flexibility to incorporate skilled providers from other regions will likely be a topic of debate among stakeholders.

Companion Bills

TX HB2345

Relating to the performance and appeal of utilization review by and under the direction of physicians.

Previously Filed As

TX HB4326

Relating to the direction of utilization review by physicians.

TX HB4343

Relating to health benefit plan preauthorization requirements for certain health care services and the direction of utilization review by physicians.

TX SB1724

Relating to advance directives and health care treatment decisions made by or on behalf of patients, including a review of those directives and decisions.

TX SB1952

Relating to advance directives and health care treatment decisions made by or on behalf of patients, including a review of those directives and decisions.

TX HB5113

Relating to utilization review requirements for a health care service provided by a network physician or provider.

TX HB3162

Relating to advance directives, do-not-resuscitate orders, and health care treatment decisions made by or on behalf of certain patients, including a review of directives and decisions.

TX HB2556

Relating to the licensing and regulation of physician graduates and the authority of an insured to select a physician graduate under the insured's health insurance policy; requiring an occupational license; authorizing fees.

TX HB593

Relating to the provision of direct patient care by physicians and health care practitioners.

TX HB3567

Relating to requirements for the renewal of a physician's registration permit and the delegation by a physician of certain medical acts.

TX HB1293

Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.

Similar Bills

CA AB2237

Children and youth: transfer of specialty mental health services.

HI SB326

Relating To Health.

HI HB15

Relating To Health.

CA AB2107

Clinical laboratory testing.

AR HB1835

Concerning Specialty Court Programs; And To Update And Clarify The Law Concerning Drug Court, Mental Health Court, Veterans Court, And Dwi/bwi Specialty Court Programs.

NJ A5344

Requires Department of Agriculture and certain consulting agency partners to study and report on regulatory compliance cost obligations of specialty crop growers.

NJ A732

Requires Department of Agriculture and certain consulting agency partners to study and report on regulatory compliance cost obligations of specialty crop growers.

LA SB285

Provides for determination of unfunded accrued liability payments. (gov sig) (OR +$415,000,000 FC GF EX)